2096-21-1

Basic information

• Product Name: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE
• Synonyms: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE
• CAS NO: 2096-21-1
• Molecular Formula: C6H7ClN2O2
• Molecular Weight: 174.59
• Mol File: 2096-21-1.mol
• Article Data: 5

Chemical Properties

• Melting Point: 126 °C
• Boiling Point: 304.7±37.0 °C(Predicted)
• Appearance: /
• Density: 1.285±0.06 g/cm3(Predicted)
• PKA: 1.42±0.10(Predicted)
• CAS DataBase Reference: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE(2096-21-1)
• EPA Substance Registry System: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE(2096-21-1)

Safety Data

• Hazardous Substances Data: 2096-21-1(Hazardous Substances Data)

Usage

Properties

1. Chemical name: 6-CHLORO-3,4-DIMETHOXYPYRIDAZINE
2. Molecular formula: C7H8ClN3O2
3. Contains a chloro group and two methoxy groups
4. Potential applications in pharmaceutical and agrochemical industries

Specific Content

1. Pyridazine derivative
2. Building block in synthesis of pharmacologically active compounds
3. Intermediate in production of agrochemicals
4. Ongoing research and development to explore potential uses and properties in various chemical and industrial applications

Upstream product

• 67-56-1 methanol 
• 6082-66-2 3,4,6-trichloropyridazine 
• 124-41-4 sodium methylate 
• 70952-62-4 3,6-dichloro-4-methoxy-1,2-dihydropyridazine 
• 112342-58-2 4,6-dichloro-3-methoxypyridazine 

Downstream Products

• 1581767-59-0 4-(5,6-dimethoxypyridazin-3-yl)benzonitrile 
• 1581767-60-3 4-(5-methoxy-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile 
• 1581767-57-8 6-(4-fluorophenyl)-3,4-dimethoxypyridazine 
• 1581767-58-9 6-(4-fluorophenyl)-4-methoxypyridazin-3(2H)-one 

Relevant articles and documents

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.

THERAPEUTIC HYDROXYPYRIDINONES, HYDROXYPYRIMIDINONES AND HYDROXYPYRIDAZINONES

The invention provides compounds of formula (I): and salts and prodrugs thereof wherein R4, X1 and X2 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.

On the characterization of 4-nitropyridazine 1-oxide and the N-oxidation of 4-methoxypyridazines.

-